Page 91 - 南京医科大学自然版

第45卷第5期 计雨佳，张恩瑞，钱 雯，等. 心肌瘢痕与药物治疗反应对非缺血性心肌病心衰患者室性心律失常
2025年5月 风险的影响［J］. 南京医科大学学报（自然科学版），2025，45（5）：671-677 ·677 ·

timodal imaging for MACE in STEMI patients after prima⁃ myocardial fibrosis and ventricular arrhythmias in pa⁃
ry PCI［J］.Journal of Nanjing Medical University（Natural tients with a left ventricular ejection fraction >35［J］. Eu⁃
Sciences），2024，44（11）：1525-1533 ropace，2022，24（1）：31-39
［6］ HALLIDAY B P，BAKSI A J，GULATI A，et al. Outcome ［16］DI MARCO A，BROWN P F，BRADLEY J，et al. Improved
in dilated cardiomyopathy related to the extent，location， risk stratification for ventricular arrhythmias and sudden
and pattern of late gadolinium enhancement［J］. JACC death in patients with nonischemic dilated cardiomyopa⁃
Cardiovasc Imaging，2019，12（8 Pt 2）：1645-1655 thy［J］. J Am Coll Cardiol，2021，77（23）：2890-2905
［7］ KLEM I，KLEIN M，KHAN M，et al. Relationship of LVEF ［17］ANAGNOSTOPOULOS I，KOUSTA M，KOSSYVAKIS C，
and myocardial scar to long⁃term mortality risk and mode et al. The prognostic role of late gadolinium enhancement
of death in patients with nonischemic cardiomyopathy［J］. on cardiac magnetic resonance in patients with nonisch⁃
Circulation，2021，143（14）：1343-1358 emic cardiomyopathy and reduced ejection fraction，im⁃
［8］ DI MARCO A，BROWN P，MATEUS G，et al. Late gado⁃ planted with cardioverter defibrillators for primary preven⁃
linium enhancement and the risk of ventricular arrhyth⁃ tion. A systematic review and meta⁃analysis［J］. J Interv
mias and sudden death in NYHA class I patients with non Card Electrophysiol，2022，63（3）：523-530
⁃ischaemic cardiomyopathy［J］. Eur J Heart Fail，2023，25 ［18］HALLIDAY B P，GULATI A，ALI A，et al. Association be⁃
（5）：740-750 tween midwall late gadolinium enhancement and sudden
［9］ GUTMAN S J，COSTELLO B T，PAPAPOSTOLOU S，et cardiac death in patients with dilated cardiomyopathy and
al. Reduction in mortality from implantable cardioverter⁃ mild and moderate left ventricular systolic dysfunction［J］.
defibrillators in non⁃ischaemic cardiomyopathy patients is Circulation，2017，135（22）：2106-2115
dependent on the presence of left ventricular scar［J］. Eur ［19］CHEN W，QIAN W，ZHANG X，et al. Ring⁃like late gado⁃
Heart J，2019，40（6）：542-550 linium enhancement for predicting ventricular tachyar⁃
［10］YI J E，PARK J，LEE H J，et al. Prognostic implications rhythmias in non ⁃ ischaemic dilated cardiomyopathy［J］.
of late gadolinium enhancement at the right ventricular in⁃ Eur Heart J Cardiovasc Imaging，2021，22（10）：1130-
sertion point in patients with non⁃ischemic dilated cardio⁃ 1138
myopathy：a multicenter retrospective cohort study［J］. ［20］DUCHENNE J，LARSEN C K，CVIJIC M，et al. Mechani⁃
PLoS One，2018，13（11）：e0208100 cal dyssynchrony combined with septal scarring reliably
［11］BONDARENKO O，BEEK A M，HOFMAN M B，et al. Stan⁃ identifies responders to cardiac resynchronization therapy
dardizing the definition of hyperenhancement in the quan⁃ ［J］. J Clin Med，2023，12（18）：6108
titative assessment of infarct size and myocardial viability ［21］LINHART M，DOLTRA A，ACOSTA J，et al. Ventricular
using delayed contrast⁃enhanced CMR［J］. J Cardiovasc arrhythmia risk is associated with myocardial scar but not
Magn Reson，2005，7（2）：481-485 with response to cardiac resynchronization therapy［J］，
［12］BECKER M A J，CORNEL J H，VAN DE VEN P M，et al. Europace，2020，22（9）：1391-1400
The prognostic value of late gadolinium⁃enhanced cardiac ［22］VAN DER HEIJDEN A C，HÖKE U，THIJSSEN J，et al.
magnetic resonance imaging in nonischemic dilated car⁃ Super⁃responders to cardiac resynchronization therapy re⁃
diomyopathy：a review and meta⁃analysis［J］. JACC Car⁃ main at risk for ventricular arrhythmias and benefit from
diovasc Imaging，2018，11（9）：1274-1284 defibrillator treatment［J］. Eur J Heart Fail，2014，16
［13］OTA S，ORII M，NISHIGUCHI T，et al. Implications of （10）：1104-1111
multiple late gadolinium enhancement lesions on the fre⁃ ［23］GYÖNGYÖSI M，WINKLER J，RAMOS I，et al. Myocardi⁃
quency of left ventricular reverse remodeling and progno⁃ al fibrosis：biomedical research from bench to bedside［J］.
sis in patients with non ⁃ ischemic cardiomyopathy［J］. J Eur J Heart Fail，2017，19（2）：177-191
Cardiovasc Magn Reson，2021，23（1）：32 ［24］PACKER M. Autophagy stimulation and intracellular sodi⁃
［14］LEYVA F，ZEGARD A，OKAFOR O，et al. Myocardial fi⁃ um reduction as mediators of the cardioprotective effect of
brosis predicts ventricular arrhythmias and sudden death sodium⁃glucose cotransporter 2 inhibitors［J］. Eur J Heart
after cardiac electronic device implantation［J］. J Am Coll Fail，2020，22（4）：618-628
Cardiol，2022，79（7）：665-678 ［收稿日期］ 2024-12-29
［15］ZEGARD A，OKAFOR O，DE BONO J，et al. Greyzone （本文编辑：唐 震）